WeVote
Log In

Bill

Bill

HF 3934

PFAS biomonitoring funding provided, and money appropriated.

2025-2026 Regular Session Introduced by Ethan Cha and 1 co-sponsor

HF 3934 authorizes and funds PFAS biomonitoring in Minnesota to measure human exposure, inform public health actions, and guide policy decisions.

Introduction and first reading, referred to Environment and Natural Resources Finance and Policy
#appropriations #environment #pollutionandpollutioncontrolagency
0
WeVote Research Nonpartisan
Bill Summary · HF 3934

Summary of HF 3934 (2025-2026) — Minnesota

What this bill does (purpose and intent)

HF 3934 authorizes and funds PFAS biomonitoring activities in Minnesota. The main goal is to measure and track human exposure to PFAS compounds (per- and polyfluoroalkyl substances) among Minnesotans, using biomonitoring data to inform public health actions, policy decisions, and program improvements. The bill combines authorization for biomonitoring activities with a dedicated appropriation to support implementation and ongoing monitoring.

Key provisions and changes

  • Authorization for PFAS biomonitoring: The bill establishes or expands a program to collect biomonitoring data related to PFAS exposure. This likely includes blood or urine testing of participants and associated data collection, analysis, and reporting.

  • State funding / appropriation: HF 3934 provides a funding appropriation to support biomonitoring activities. The exact dollar amount is not provided in the summary, but the bill designates financial resources to cover program operations, laboratory analyses, data management, and reporting.

  • Program administration: The bill would specify oversight and administration mechanisms, potentially involving a state health department or a designated agency (often the Minnesota Department of Health or a partner agency) responsible for implementing the biomonitoring program, setting protocols, ensuring quality control, and safeguarding participant privacy.

  • Data reporting and use: Provisions are expected to detail how biomonitoring results are communicated to participants, how aggregated data are reported to the public, and how findings inform public health guidance or regulatory actions regarding PFAS exposure.

  • Collaboration and compliance: The bill may authorize collaboration with healthcare providers, labs, and researchers, and require adherence to ethical, privacy, and consent standards for biomonitoring activities.

  • Timeline and milestones: The measure may outline phased implementation (pilot, expansion) and reporting milestones, along with ongoing evaluation of program effectiveness. The introduction and first reading occurred on March 5, 2026, with referral to the Environment and Natural Resources Finance and Policy committee, indicating the bill’s focus on environmental health and funding considerations.

Who is affected

  • Minnesotans: Individuals who participate in biomonitoring studies or are represented in the program by clinical partners or communities of interest.
  • Public health system: State agencies (likely the Department of Health) responsible for running the biomonitoring program, data management, and public communication.
  • Laboratories and healthcare providers: Entities involved in collecting samples, performing analyses, and reporting results in a privacy-conscious manner.
  • Policy makers and communities: Data produced will inform environmental and public health policies, interventions, and potential regulatory actions related to PFAS.

Procedural and timeline aspects

  • Legislative action: Introduced and referred on 2026-03-05 to the Environment and Natural Resources Finance and Policy committee.
  • Next steps: The bill will undergo committee hearings, possible amendments, and floor action. If advanced, it would proceed to further committees and potential floor votes, with appropriations and implementation timelines determined through the fiscal and policy process.
  • Budget linkage: Funding authorization is a core element, linking biomonitoring activities to the state budget and annual appropriations cycles.

Notes

  • As of the provided information, specific dollar figures, detailed program structure, and exact implementation dates are not included. The summary focuses on the bill’s stated purpose to fund and implement PFAS biomonitoring and the general scope of activities and affected parties.

If you would like, I can tailor this summary to include modeled potential fiscal impacts or compare it to existing Minnesota PFAS biomonitoring efforts and related legislation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.